Solventum Corporation (SOLV)Healthcare | Medical Instruments & Supplies | Eagan, United States | NYSE
87.97 USD
+0.71
(0.814%)
⇧
(Oct. 15, 2026, 3:31 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 2:54 a.m. EDT
Solventum presents a classic value-versus-risk dilemma. The company boasts exceptional profitability with a 34 percent return on equity and healthy profit margins, trading at a modest price-to-book ratio. However, the balance sheet carries significant weight with a debt-to-equity ratio exceeding 110 percent, which constrains the fortress status needed for top-tier long-term ratings. Growth is sluggish at just 2 percent annually, and there is no dividend history to rely on for income investors. On the short end, technicals show the stock holding above its 200-day average, supported by analyst price targets suggesting roughly 8 percent upside. Options flow confirms this bullish lean, with heavy positioning in calls further out in time. While the business quality is strong, the leverage and lack of growth acceleration keep it from being a definitive buy-and-hold winner. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.129095 |
| AutoETS | 0.130748 |
| AutoARIMA | 0.130749 |
| MSTL | 0.134940 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 1.92 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 2.23 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 110.313 |
| Revenue per Share | 47.786 |
| Market Cap | 14,974,581,760 |
| Trailing P/E | 10.65 |
| Forward P/E | 12.14 |
| Beta | 0.70 |
| Profit Margins | 17.26% |
| Website | https://www.solventum.com |
As of Oct. 10, 2026, 2:54 a.m. EDT: Speculators are heavily weighting upside exposure, with open interest concentrated in out-of-the-money calls targeting $100 to $110 strikes. ATM call volume is moderate, while put activity remains centered at the money, suggesting a bullish bias despite elevated implied volatility on distant strikes.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.2214446 |
| Address1 | 1,750 Yankee Doodle Road |
| All Time High | 96.05 |
| All Time Low | 47.16 |
| Ask | 88.05 |
| Ask Size | 200 |
| Audit Risk | 10 |
| Average Analyst Rating | 2.2 - Buy |
| Average Daily Volume10 Day | 1,042,530 |
| Average Daily Volume3 Month | 1,054,756 |
| Average Volume | 1,054,756 |
| Average Volume10Days | 1,042,530 |
| Beta | 0.703 |
| Bid | 87.99 |
| Bid Size | 300 |
| Board Risk | 3 |
| Book Value | 28.216 |
| City | Eagan |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 87.97 |
| Current Ratio | 1.021 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 89.45 |
| Day Low | 87.255 |
| Debt To Equity | 110.313 |
| Display Name | Solventum |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,785,961,800 |
| Earnings Call Timestamp Start | 1,785,961,800 |
| Earnings Growth | 0.039 |
| Earnings Quarterly Growth | 0.022 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | 1,139,000,064 |
| Ebitda Margins | 0.13706 |
| Enterprise To Ebitda | 17.336 |
| Enterprise To Revenue | 2.376 |
| Enterprise Value | 19,745,722,368 |
| Eps Current Year | 7.14316 |
| Eps Forward | 7.24698 |
| Eps Trailing Twelve Months | 8.26 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 20 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 88.3664 |
| Fifty Day Average Change | -0.39640045 |
| Fifty Day Average Change Percent | -0.004485873 |
| Fifty Two Week Change Percent | 22.14446 |
| Fifty Two Week High | 94.16 |
| Fifty Two Week High Change | -6.1900024 |
| Fifty Two Week High Change Percent | -0.06573919 |
| Fifty Two Week Low | 62.38 |
| Fifty Two Week Low Change | 25.59 |
| Fifty Two Week Low Change Percent | 0.41022763 |
| Fifty Two Week Range | 62.38 - 94.16 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,711,459,800,000 |
| Float Shares | 144,089,280 |
| Forward Eps | 7.24698 |
| Forward P E | 12.138849 |
| Free Cashflow | 489,000,000 |
| Full Exchange Name | NYSE |
| Full Time Employees | 20,584 |
| Fullday Change | 0.7099991 |
| Fullday Change Percent | 0.81365925 |
| Fullday Price | 87.97 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.54777 |
| Gross Profits | 4,552,000,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15342 |
| Held Percent Institutions | 0.75883 |
| Implied Shares Outstanding | 170,223,729 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota. |
| Long Name | Solventum Corporation |
| Market | us_market |
| Market Cap | 14,974,581,760 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_1871945009 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 1,434,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 15,042,670,931 |
| Number Of Analyst Opinions | 13 |
| Open | 88.81 |
| Operating Cashflow | 209,000,000 |
| Operating Margins | 0.09778 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.22 |
| Phone | (651) 733-1110 |
| Previous Close | 87.26 |
| Price Eps Current Year | 12.315278 |
| Price Hint | 2 |
| Price To Book | 3.1177347 |
| Price To Sales Trailing12 Months | 1.8019954 |
| Profit Margins | 0.17256 |
| Quick Ratio | 0.501 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.2 |
| Region | US |
| Regular Market Change | 0.7099991 |
| Regular Market Change Percent | 0.81365925 |
| Regular Market Day High | 89.45 |
| Regular Market Day Low | 87.255 |
| Regular Market Day Range | 87.255 - 89.45 |
| Regular Market Open | 88.81 |
| Regular Market Previous Close | 87.26 |
| Regular Market Price | 87.97 |
| Regular Market Time | 1,792,092,678 |
| Regular Market Volume | 547,877 |
| Return On Assets | 0.026989998 |
| Return On Equity | 0.33960998 |
| Revenue Growth | 0.022 |
| Revenue Per Share | 47.786 |
| Sand P52 Week Change | 0.16440773 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 170,223,729 |
| Shares Percent Shares Out | 0.028800001 |
| Shares Short | 4,894,684 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 4,299,252 |
| Short Name | Solventum Corporation |
| Short Percent Of Float | 0.0339 |
| Short Ratio | 5.55 |
| Source Interval | 15 |
| State | MN |
| Symbol | SOLV |
| Target High Price | 113.0 |
| Target Low Price | 71.0 |
| Target Mean Price | 94.69231 |
| Target Median Price | 100.0 |
| Total Cash | 403,000,000 |
| Total Cash Per Share | 2.367 |
| Total Debt | 5,295,000,064 |
| Total Revenue | 8,310,000,128 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 8.26 |
| Trailing P E | 10.650121 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 78.18935 |
| Two Hundred Day Average Change | 9.780655 |
| Two Hundred Day Average Change Percent | 0.12508936 |
| Type Disp | Equity |
| Volume | 547,877 |
| Website | https://www.solventum.com |
| Zip | 55,121 |